Management and prevention of erythroblastosis fetalis.
D000653:Amniotic Fluid / Q000032:analysis; D000906:Antibodies / Q000032:analysis; D001663:Bilirubin / Q000032:analysis; D001805:Blood Transfusion, Intrauterine; D004899:Erythroblastosis, Fetal / Q000517:prevention & control / Q000628:therapy*; D005260:Female; D006087:Graft vs Host Reaction; D006801:Humans; D011247:Pregnancy; D011295:Prenatal Care; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use
D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins; D001663:Bilirubin